Refine your search
Collections
Co-Authors
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Haque, N.
- Overview of Confocal Microscopy and Usage in Cystic Fibrosis
Abstract Views :325 |
PDF Views:313
Authors
Affiliations
1 Department of Biomedicine and Methods in Medical Diagnostics, Orebro University 70182, SE
1 Department of Biomedicine and Methods in Medical Diagnostics, Orebro University 70182, SE
Source
Indian Journal of Medicine and Healthcare, Vol 2, No 7 (2013), Pagination: 281-291Abstract
The aim of this study was staining of NOD1, NOD2 and CFTR receptors and its visualization by using light and confocal microscopy. Also it describes uses and advantages of confocal microscopy over other techniques, details of cystic fibrosis disease, pathophysiology, clinical features, prevalence, diagnosis and treatment. The results indicated marked expression of CFBE cell lines when visualized under confocal microscopy.Keywords
Confocal Microscopy, Laser Scanning Confocal Microscope, Cystic Fibrosis NOD1, NOD2, CFTRFull Text
References
- Paddock S W (2000). Principles and practices of laser scanning confocal microscopy, Molecular Biotechnology, vol 16(2), 128–149.
- Olympus confocal microscope manufacturers’ webpage [Homepage on internet], Available from: www.olympusfluoview.com/theory/index.html
- Alberts B, Johnson A et al. (2002). Molecular biology of the cell, [Monograph on the Internet] New York: Garland Science, Available from: http://www.ncbi.nlm.nih.gov/books/NBK26880/#A1745
- Lodish H, Berk A et al. (2000). Molecular cell biology, [Monograph on the Internet], New York: W. H. Freeman, 4th edition, Available from: http://www.ncbi.nlm.nih.gov/books/NBK21629/#A1086]
- Lodish H, Berk A et al. (2000). Molecular cell biology. [Monograph on the Internet]. New York: W. H. Freeman, 4th Edn., Available from: http://www.ncbi.nlm.nih.gov/books/NBK26880/#A1722]
- Zieve D, Kaneshiro N K (2010). Pubmed Health, Disease and condition, cystic fibrosis, [Monograph on the Internet], Available from: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001167
- Kumar V, Abbas A K et al. (2004). Robbins and Cotran pathological basis of disease, Elsevier Saunders, 7th Edn., 489–495.
- Narasimhan M, and Cohen R (2011). New and investigational treatments in cystic fibrosis, Therapeutic Advances in Respiratory Disease, [Epub ahead of print], DOI: 10.1177/1753465811398267, Available from: http://tar.sagepub.com/content/early/2011/03/02/1753465811398267
- Roussel L, and Rousseau S (2010). IL-17 primes airway epithelial cells lacking functional Cystic Fibrosis Transmembrane conductance Regulator (CFTR) to increase NOD1 responses, Biochemical and Biophysical Research Communications, vol 391(1), 505–509.
- Cigana C, Curcurù L (2009). Pseudomonas aeruginosa Exploits Lipid a and Muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection, PLoS One, vol 4(12), e8439.
- Donaldson S H, and Boucher R C (2006). Pathophysiology of cystic fibrosis, Ann Nestlé [Engl], vol 64, 101–109, DOI: 10.1159/000095374, Available from: www.karger.com/ane
- Proesmans M, Vermeulen F et al. (2008). What’s new in cystic fibrosis? From treating symptoms to correction of the basic defect, European Journal of Pediatrics, vol 167(8), 839–849.
- Hermanson G T (2008). Bioconjugate techniques: Academic Press, 401–403, Available from: http://books.google.com/books?id=alooWMkRMk0C&dq=FITC+bioconjugate&source=gbs_navlinks_s